Study Links Long Sleep Duration to Alzheimer's Biomarkers

Published in the journal Alzheimer's and Dementia, the study analyzed data from 2,410 participants in the Framingham Heart Study, with an average age of 70. Participants reported their typical sleep duration and provided blood samples for biomarker analysis. The results showed that those who reported sleeping more than 8.5 hours had increased levels of the blood biomarker p-tau181, suggesting a potential early indicator of Alzheimer’s pathology.

Dr. Steven Allder, a consultant neurologist at Re:Cognition Health, noted that this research adds to the growing evidence linking sleep changes to the biological processes of Alzheimer’s rather than merely aging effects. In the cohort, 24% reported short sleep (up to 6 hours), 61% average sleep (6-9 hours), and 15% long sleep (more than 9 hours). Individuals with longer sleep were often older and more likely to have depression and dementia.

The study also suggests that while those who slept longer showed elevated biomarkers, the increase was significant only for p-tau181. This biomarker exhibited a J-shaped curve, increasing gradually with longer sleep durations and sharply at 10 or more hours of sleep. Researchers acknowledged that while associations were found, causation could not be established, and sleep changes might be influenced by early neurodegenerative processes.

Dr. Vanessa M. Young, a corresponding author of the study, emphasized that the findings warrant monitoring sleep patterns but do not definitively indicate that longer sleep causes Alzheimer's. Rather, it remains unclear if longer sleep is a symptom of emerging dementia. Allder highlighted the importance of assessing overall brain health and maintaining good sleep hygiene alongside other lifestyle factors to support cognitive well-being.